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ABSTRACT
Objective: The purpose of this study was to determine if granulocyte colony-stimulating factor
(G-CSF) is normally present in amniotic fluid and then to determine if amniotic-fluid G-CSF levels
are affected by labor and intrauterine infection.
Methods: Amniotic fluid was collected from 35 patients in 4 groups: no labor, early labor, late
labor, and labor plus chorioamnionitis. G-CSF levels were measured by enzyme-linked immunosor-
bent assay (ELISA).
Results: The mean amniotic-fluid G-CSF concentrations prior to labor were lower than during
labor (0.49 +- 0.25 ng/ml for prior to labor vs. 1.83 +- 1.0 ng/ml for labor,P < 0.001). With chorioam-
nionitis, the mean levels were elevated compared with normal labor (25.0 4.8 ng/ml for chorioam-
nionitis vs. 1.83 _+ 1.0 ng/ml for normal labor, P < 0.0001). In early and late labor, G-CSF was
higher than prior to labor (0.49 _+ 0.25 ng/ml for no labor vs. 1.48 + 1.0 ng/ml for early labor,
P < 0.02, vs. 2.2 +__ 0.8 ng/ml for late labor, P < 0.0005). The mean concentrations in early and late
labor were not different.
Conclusions: G-CSF is present in amniotic fluid and increased with labor. When labor is compli-
cated by chorioamnionitis, G-CSF is significantly elevated. (C) 1995 Wiley-Liss, Inc.
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ranulocyte colony-stimulating factor (G-CSF)
is a hematopoietic growth factor that stimu-
lates the differentiation of neutrophils and enhances
neutrophil function. It acts at several sites: stimu-
lating the proliferation of progenitor cells in bone
marrow, accelerating the differentiation of mature
forms, and enhancing chemotaxis and phagocytosis
through priming of the cellular metabolism associ-
ated with oxidative burst. G-CSF is synthesized by
fibroblasts, endothelial cells, macrophages, placen-
tal cells, and decidua.
At birth, the host defenses in neonates are imma-
ture. Frequently, newborns respond to sepsis with
neutropenia because oflow mature-neutrophil storage
and myeloid progenitor-cell pools. In addition, when
compared with adults, mature neonatal neutrophils
have qualitative deficiencies in neutrophil activation,
chemotaxis, phagocytosis, and bacterial killing.
Recombinant G-CSF (rG-CSF) has been shown
to cross the placenta and decrease neonatal mortality
in experimentally induced sepsis in animal mod-
els.
1,2 The maternal administration of rG-CSF to
improve neonatal survival from peripartum infec-
tion has recently been considered. However, the
data on G-CSF concentrations in normal newborn
serum are conflicting, with some studies showing
minimal amounts of the stimulating factor and oth-
ers showing elevated amounts compared with
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adults.
3.s Little information is available on serum
levels of G-CSF in infected neonates.
The source of G-CSF in amniotic fluid is un-
clear. While placental macrophages and decidual
cells synthesize this factor, the fetus may contribute
to amniotic-fluid concentrations, especially when
infected. Both the presence and source ofG-CSF in
amniotic fluid may have some bearing on the effi-
cacy of the intrapartum administration of rG-CSF.
We sought to determine the normal levels of
G-CSF in amniotic fluid and any change in these
levels during labor and in the presence of chorio-
amnionitis.
SUBJECTS AND METHODS
The study was conducted at Shands Hospital, Uni-
versity of Florida, Gainesville, between April and
June of 1994. Our institution serves primarily a
rural, indigent patient population. This study was
approved by the institutional review board. A
signed consent form was not required in the proto-
col because the collection of amniotic-fluid speci-
mens posed no risk to the patient or her fetus.
However, verbal permission was obtained from
each patient prior to the amniotic-fluid collection.
Amniotic fluid was collected from patients in 4
groups selected at random based on the availability
of the investigators: 1) those not in labor, 2) those
in early labor (defined as <4-cm cervical dilation),
3) those in late labor (defined as near delivery, after
complete cervical dilation), and 4) those in labor
with clinical chorioamnionitis. Chorioamnionitis
was diagnosed by the physician caring for the pa-
tient if she developed a fever >38C in association
with maternal or fetal tachycardia and uterine ten-
derness in the absence of any other localizing signs
of infection. The amniotic-fluid specimens were
collected after the diagnosis was made without re-
gard to cervical dilation. A patient was excluded
from the first 3 groups if she developed the signs of
chorioamnionitis after the specimen was collected.
No patient received amnioinfusion prior to the spec-
imen collection. The amniotic fluid was collected
by needle aspiration at the time of the uterine inci-
sion during a cesarean delivery or by aspiration
through an intrauterine pressure catheter that had
been placed for the usual obstetrical indications.
The amniotic fluid was aspirated from the pressure
catheter using a sterile syringe. The initial 10 cc of
fluid was discarded, and the next 10-15 cc was
aspirated into a fresh sterile syringe., which was
capped after expelling the air and transported to the
research laboratory within 30 min of collection.
6
The amniotic fluid was centrifuged at 3,900g
for 10 min; the supernatant was collected and stored
at -80C. None of the samples was meconium-
stained. G-CSF was measured using duplicate sam-
ples by commercial enzyme-linked immunosorbent
assay (ELISA) (R&D Systems, Minneapolis,
MN). The double antibody sandwich assay used a
murine monoclonal anti-G-CSF antibody as the
capture antibody and a polyclonal anti-G-CSF con-
jugated to horseradish peroxidase as the detecting
agent. G-CSF concentrations were determined by
reference to a standard curve of known concentra-
tions of human rG-CSF. The assay had no cross
reactivity with interleukin-1 (IL-1), IL-2, IL-3,
IL-6, IL-8, tumor necrosis factor (TNF), or gran-
ulocyte-macrophage colony stimulating factor (G-
CSF). The lower limit of detection was 15 pg/ml.
The mean of the 2 measurements was used when
analyzing the results. The intra-assay coefficient of
variance was 5.5%.
The maternal age and parity, gestational age at
delivery, mode of delivery, duration of ruptured
membranes, interval between specimen collection
and delivery, and use of oxytocin were recorded.
The differences in categorical variables were an-
alyzed with the corrected chi-squared test. The dif-
ferences between continuous variables were assessed
by the Mann-Whitney U-test for non-normally dis-
tributed variables such as G-CSF levels and the
2-tailed, paired t-test for normally distributed vari-
ables such as gestational age and duration of labor.
The correlation was performed by Spearman rank
test. P < 0.05 was considered statistically significant.
RESULTS
The study group consisted of 35 patients: those not
in labor (7), those in early labor (9), those in late
labor (9), and those in labor with chorioamnionitis
(10). The complications of pregnancy included
postdates (2) and preterm delivery (1) in the 2
laboring groups; previous cesarean (3), fetal mac-
rosomia (2), and preeclampsia (2) in the no labor
group; and spontaneous premature rupture of the
membranes (2), preeclampsia (2), polyhydramnios
(1), and gestational diabetes (!) in the chorioam-
nionitis group.
The use of oxytocin and the method of delivery
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TABLE I. Use of oxytocin and method of delivery
in study patients
Group (no.) Oxytocin Cesarean
Early labor (9) 8
Late labor (9) 8
Chorioamnionitis (10) 9 7
Prelabor (7) 7
are detailed in Table 1. Thirteen (37%) of the 35
amniotic-fluid specimens were collected at the time
of cesarean: 5 in patients with chorioamnionitis,
late in labor, and 7 prior to labor. The indications
for cesarean delivery in the study population were
arrest of labor (7), previous cesarean (3), nonreas-
suring fetal heart rate tracing (2), malpresentation
(2), and macrosomia (2). All but 2 of the intrauter-
ine pressure catheters were placed to monitor oxyto-
cin administration, either for augmentation or in-
duction of labor. One catheter was inserted because
ofan inadequate tocodynameter recording and for
an amnioinfusion for variable decelerations.
The mean gestational ages were 36 + 4 weeks
for patients without labor, 40 2 weeks for those
in early labor, 38 4 weeks for those in late labor,
and 38 + 3 weeks for those in labor with chorio-
amnionitis. These differences were not statisti-
cally significant. The 2 patients without labor who
delivered preterm infants account for the lower
mean gestational age in that group. Both had pre-
eclampsia.
In the early labor group, samples of amniotic
fluid were collected, a mean of 6 + 4 h prior to
delivery, significantly longer than the + h in
the late labor group (P < 0.001), but not longer
than the 2 + 3 h in the group with chorioamnioni-
tis. The patients with chorioamnionitis had a sig-
nificantly longer interval with ruptured mem-
branes, 13 + 7 h, compared with those in the early
and late labor groups, 8 --+ 4 and 6 3 h, respec-
tively (P < 0.01). The infected patients were more
likely to be delivered by cesarean (P < 0.005).
The mean G-CSF concentrations in the patients
prior to the beginning of labor were significantly
lower than those in labor (0.49 + 0.25 ng/ml for
prelabor vs. 1.83 1.0 ng/ml for labor, P < 0.001)
(Fig. 1). In patients with chorioamnionitis, the mean
amniotic-fluid levels were significantly elevated com-
pared with those in labor (25.0 --+ 4.8 ng/ml for
chorioamnionitis vs. 1.83 + 1.0 ng/ml for labor,
30.0
22.5
ng/ml
15.0
7.5
0.0
chorio early late no
Fig. I. Amniotic-fluid G-CSF levels in chorioamnionitis, early
labor, late labor, and prior to labor. Bars represent means.
P < 0.00001) and prior to labor (0.49 + 0.25
ng/ml, P < 0.00001). While mean G-CSF levels
in both early and late labor were significantly higher
than prelabor (0.49 ---
0.25 ng/ml for prelabor vs.
1.48 +-- 1.0 ng/ml for early labor, P < 0.02, vs.
2.2 + 0.8 ng/ml for late labor, P < 0.0005), there
was no difference between early and late labor.
However, there was a significant correlation be-
tween G-CSF levels and the interval between the
specimen collection and delivery (R 0.50,
P < 0.05); i.e., G-CSF levels tended to rise as
labor continued. G-CSF levels correlated with nei-
ther gestational age nor cervical dilation, even when
the significantly higher levels in the chorioamnion-
itis group were excluded.
DISCUSSION
G-CSF is a major modulator of neutrophil func-
tion, affecting both the number and activity of
these cells. Our study showed that G-CSF is present
in the amniotic fluid at term and increases with the
duration of labor. In the presence of clinical chori-
oamnionitis, a 10-fold elevation in amniotic-fluid
G-CSF levels occurs. This increase presumably re-
flects the increase in WBCs seen in infected amni-
otic fluid. These findings support those of Saito
et al., 7’8 who reported increased amniotic-fluid
G-CSF levels in women in labor and a further
increase when histologic evidence ofchorioamnion-
itis was identified or bacterial endotoxin was present
in the amniotic fluid. Our study patients were some-
what different from those in the previous study
since histologic chorioamnionitis and amniotic-fluid
bacterial endotoxin can be seen in subclinical in-
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traamniotic infection without the overt signs of clin-
ical chorioamnionitis.
A number of the shortcomings in our study
should be mentioned. While the women included
in the laboring groups had essentially uncompli-
cated pregnancies, some pregnancies in the chorio-
amnionitis and prelabor groups were complicated
by preeclampsia and gestational diabetes. The ques-
tion of whether either of these diseases has an effect
on G-CSF concentrations is unexplored. The simi-
larity of the specimens of G-CSF concentrations in
the presence of infection would suggest that infec-
tion is the major stimulus for G-CSF secretion. It is
also possible that our sample of patients in labor
may not be representative of normal labor since the
majority of laboring patients received oxytocin.
However, all but 2 were delivered vaginally, sug-
gesting that the labor patterns ultimately normal-
ized. Lastly, our study was limited by the small
sample size.
The source of amniotic-fluid G-CSF is as yet
unclear. Decidual macrophages have been shown to
synthesize G-CSF, while cytotrophoblasts and stro-
mal cells do not appear to produce this stimulating
factor.
9 However, immunohistochemical studies
have localized G-CSF to decidual stromal cells and
trophoblasts,
8 and receptors have been demon-
strated on placental membranes and trophoblasts.
10
Nonpregnant adults have undetectable or low
serum G-CSF levels which rise significantly with
acute infection.
11 Information on serum concentra-
tions in pregnancy is limited to a small sample
which showed no correlation between maternal se-
rum levels and infection, although G-CSF was ele-
vated in one-fifth of the mothers studied.
14
Little is known about fetal G-CSF production.
While Laver et al.
3 reported higher G-CSF con-
centrations in term neonates than adults, neither
Cairo et al. s nor Bailie et a|. 4 found high stimulat-
ing factor levels in umbilical cord blood from term
neonates.
3-s The latter study found preterm neo-
nates had elevated G-CSF concentrations when com-
pared with term infants, but Gessler et al.
12 re-
ported that neonates between 26 and 37 weeks
gestation had lower cord blood levels than those
born after 37 weeks. The neonates born to mothers
with signs of maternal infection had 4-fold higher
G-CSF levels soon after birth than those born to
uninfected mothers, and the newborns who devel-
oped actual infections had a 7-fold increase corn-
pared with those without infections. The elevated
G-CSF levels, however, did not result in a statisti-
cally significant increase in the total neutrophil
count.
G-CSF mRNA production by mononuclear cells
from both umbilical cord blood and adult blood has
been shown to be negligible. With stimulation,
G-CSF mRNA expression was lower in mononu-
clear cell cultures from neonates than adults and
was even lower in cells cultured from preterm neo-
nates, s’l This finding may explain the lower se-
rum G-CSF concentrations in neonates than adults.
Further studies are needed to determine the basal
fetal production of G-CSF, the maternal and fetal
contributions to the concentration ofG-CSF in am-
niotic fluid, and the way in which these factors may
affect fetal and neonatal responses to sepsis.
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